Your session is about to expire
← Back to Search
7T MRI for Studying Addiction
N/A
Recruiting
Led By Reza Momenan, Ph.D.
Research Sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Between 18-65 years of age
Be older than 18 years old
Must not have
Are currently receiving psychotropic medication
Inpatients only: Currently experiencing symptoms of withdrawal from alcohol (As determined by the most recent measurement within the past 30 days CIWA score > 8)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up ongoing
Awards & highlights
No Placebo-Only Group
Summary
This trial is looking for healthy right-handed volunteers 18-65 years old to help develop tasks that investigate a person's behavior.
Who is the study for?
This trial is for right-handed adults aged 18-65 who are physically healthy. It's specifically for inpatients from another study and also seeks healthy volunteers. People with metal implants, pregnant individuals, those with claustrophobia or left-handedness cannot participate.
What is being tested?
The study is testing new computerized tasks to understand the behavior of people with alcohol use disorders. These tasks will be performed during a one-hour MRI scan session which may require lying still for up to 20 minutes.
What are the potential side effects?
Possible side effects include discomfort from loud noises (despite earplugs), having to lie still inside the scanner which could cause stiffness or soreness, and potential anxiety due to confinement in the MRI cylinder.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 65 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am currently taking medication for my mental health.
Select...
I am in the hospital and experiencing alcohol withdrawal symptoms.
Select...
I do not have any metal implants or fragments in my body.
Select...
I have failed a neuromotor exam.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ ongoing
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~ongoing
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
outcome is to develop and examine tasks that reliably measure specific cognitive, motivational and decision-making behaviors
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: 2Experimental Treatment1 Intervention
People without alcohol use disorder
Group II: 1Experimental Treatment1 Intervention
People with alcohol use disorder
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
7T MRI
2017
N/A
~50
Find a Location
Who is running the clinical trial?
National Institute on Alcohol Abuse and Alcoholism (NIAAA)Lead Sponsor
839 Previous Clinical Trials
1,083,248 Total Patients Enrolled
459 Trials studying Alcoholism
823,431 Patients Enrolled for Alcoholism
Reza Momenan, Ph.D.Principal InvestigatorNational Institute on Alcohol Abuse and Alcoholism (NIAAA)
9 Previous Clinical Trials
4,785 Total Patients Enrolled
8 Trials studying Alcoholism
4,751 Patients Enrolled for Alcoholism
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently taking medication for my mental health.I am between 18 and 65 years old.I am in the hospital and experiencing alcohol withdrawal symptoms.I do not have any metal implants or fragments in my body.I have failed a neuromotor exam.You are afraid of being in small or enclosed spaces.
Research Study Groups:
This trial has the following groups:- Group 1: 1
- Group 2: 2
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.